524558 Stock Overview
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 524558 from our risk checks.
Neuland Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹7,121.30 |
| 52 Week High | ₹7,794.00 |
| 52 Week Low | ₹2,006.00 |
| Beta | 1.02 |
| 1 Month Change | 10.37% |
| 3 Month Change | 16.57% |
| 1 Year Change | 238.46% |
| 3 Year Change | 192.94% |
| 5 Year Change | 927.60% |
| Change since IPO | 9,270.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524558 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -7.0% | 1.4% | 2.8% |
| 1Y | 238.5% | 57.2% | 46.6% |
Return vs Industry: 524558 exceeded the Indian Pharmaceuticals industry which returned 55.9% over the past year.
Return vs Market: 524558 exceeded the Indian Market which returned 46.4% over the past year.
Price Volatility
| 524558 volatility | |
|---|---|
| 524558 Average Weekly Movement | 7.6% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524558 has not had significant price volatility in the past 3 months.
Volatility Over Time: 524558's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 1,554 | Davuluri Rao | www.neulandlabs.com |
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial, and anti-parkinson. It also provides custom manufacturing solutions, as well as peptide synthesis services.
Neuland Laboratories Limited Fundamentals Summary
| 524558 fundamental statistics | |
|---|---|
| Market cap | ₹91.37b |
| Earnings (TTM) | ₹3.17b |
| Revenue (TTM) | ₹15.81b |
28.8x
P/E Ratio5.8x
P/S RatioIs 524558 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524558 income statement (TTM) | |
|---|---|
| Revenue | ₹15.81b |
| Cost of Revenue | ₹7.62b |
| Gross Profit | ₹8.18b |
| Other Expenses | ₹5.01b |
| Earnings | ₹3.17b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 10, 2024
| Earnings per share (EPS) | 247.13 |
| Gross Margin | 51.77% |
| Net Profit Margin | 20.06% |
| Debt/Equity Ratio | 8.9% |
How did 524558 perform over the long term?
See historical performance and comparison